logo

For the Inventor, By the Inventor

Laudenbach, Germany

Heinrich Woog

This inventor holds 20 USPTO granted patents and 1 published patent application and 2 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Boehringer Mannheim Gmbh, Roche Diagnostics Gmbh, Hoffmann-La Roche Inc.. Active years: 1978-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heinrich Woog. Retrieved from https://idiyas.com/inventor/heinrich-woog

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 90.0


Average Co-Inventor Count = 3.3

ph-index = 11

Forward Citations = 420(Granted Patents)


Location History:

  • Ludwigshafen am Rhein, DE (1978)
  • Laudenbach, DE (1980 - 2014)

Company Filing History:

goldMedal12 out of 1,164 
 
Boehringer Mannheim Gmbh
 patents
silverMedal4 out of 488 
 
Roche Diagnostics Gmbh
 patents
bronzeMedal3 out of 5,026 
 
Hoffmann-La Roche Inc.
 patents
4. 1 out of 1 
 
Heidelberg Pharma Holding Gmbh
 patent

Years Active: 1978-2014

Loading Chart...
Loading Chart...
Areas of Expertise:
Pharmaceutical Preparations
Monoclonal Antibodies
Stabilization Techniques
Injectable Solutions
Bisphosphonate Compositions
G-CSF Formulations
Instant-Release Forms
Erythropoietin Preparations
Diphosphonic Acid
Aqueous Solutions
Multi-Dose Formulations
Injection Solutions
20 patents (USPTO):Explore Patents
1. 8758747 - Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies (2014-06-24),
2. 6689755 - Method of stabilizing biologically active substances (2004-02-10),
3. 6664284 - Stabilized carvedilol injection solution (2003-12-16),
4. 6627221 - Pharmaceutical composition containing diphosphonic acid or salt thereof (2003-09-30),
5. 6521262 - Solid instant-release forms of administration and process for producing the same (2003-02-18),
6. 6419955 - Process for making bisphosphonate compositions (2002-07-16),
7. 6303113 - Process for the production of pharmaceutical preparations containing human protein for infusion or injection purposes (2001-10-16),
8. 6294196 - Pharmaceutical composition containing diphosphonic acid or salt thereof (2001-09-25),
9. 6143326 - Oral pharmaceutical preparation containing ibandronat (2000-11-07),
10. 5919757 - Aqueous pharmaceutical preparations of G-CSF with a long shelf life (1999-07-06),
11. 5919443 - Stable lyophilized pharmaceutical preparations of G-CSF (1999-07-06),
12. 5747030 - Pharmaceutical preparation containing plasminogen activators (1998-05-05),
13. 5662918 - Pharmaceutical agents containing diphosphonic acids and salts thereof (1997-09-02),
14. 5504099 - Injection solutions of azosemide which are ready for injection (1996-04-02),
15. 5503827 - Process for the production of multi-dose pharmaceutical preparations (1996-04-02),

Title: Inventor Heinrich Woog

Introduction: Heinrich Woog is a renowned inventor hailing from Laudenbach, Germany, known for his groundbreaking contributions to various fields of technology.

Latest Patents: Heinrich Woog holds several patents in the areas of renewable energy, sustainable materials, and advanced manufacturing processes.

Career Highlights: With a career spanning over two decades, Heinrich Woog has worked with leading research institutions and companies to develop innovative solutions that have had a significant impact on the industry.

Collaborations: Throughout his career, Heinrich Woog has collaborated with top engineers, scientists, and designers to bring his inventions to life, fostering a culture of creativity and excellence in the teams he works with.

Conclusion: Heinrich Woog's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…